Breast cancer develops when cells in the breast grow and divide uncontrollably, and there is no single cause. Instead, a combination of genetic, hormonal, environmental, and lifestyle factors work together to raise or lower risk. About 5% to 10% of breast cancers are hereditary, meaning they stem from gene mutations passed down from a parent. The remaining 90% or more arise from mutations that accumulate over a person’s lifetime through a mix of biological processes and external exposures.
How Hormones Drive Breast Cell Growth
Estrogen plays a central role in many breast cancers. In healthy breast tissue, estrogen binds to receptors inside cells and switches on genes involved in normal development and cell maturation. But during the early stages of tumor formation, this signaling gets reprogrammed. Genes that normally act as brakes on cell growth get silenced, while genes that push cells to multiply gain the upper hand.
One example: a protein called DLC1 normally acts as a tumor suppressor, keeping estrogen-fueled growth in check. Research published in PNAS found that when DLC1 is lost or silenced, the rate of estrogen-driven cell division nearly doubles. Without that brake, cancer-promoting proteins become free to push unchecked proliferation. A second protein, GRHL2, cooperates with the estrogen receptor to activate genes for cell cycling and DNA synthesis. When GRHL2 is removed from breast cancer cells in the lab, those growth pathways shut down almost entirely.
This is why lifetime exposure to estrogen matters so much. The longer breast cells are exposed to the hormone, the more opportunities these signaling errors have to accumulate.
Reproductive Factors That Shift Your Risk
Because estrogen exposure is so tightly linked to breast cancer, anything that changes how much estrogen your body produces over a lifetime also changes your risk. Starting menstruation early or entering menopause late extends the window of hormonal exposure. The reverse is also true: pregnancy and breastfeeding reduce your total number of menstrual cycles and, with them, your cumulative estrogen exposure.
The timing of a first pregnancy matters significantly. Women who have their first full-term pregnancy before age 20 have roughly half the breast cancer risk of women whose first pregnancy occurs after 30. Having more children also lowers risk: women who have given birth to five or more children have half the risk of women who have never given birth. And women older than 30 at their first birth actually carry a higher risk than women who never had children at all, likely because pregnancy temporarily raises hormone levels before the long-term protective effects of breast cell maturation kick in.
Breastfeeding for at least a year is associated with lower risk for both hormone receptor-positive and hormone receptor-negative breast cancers. Pregnancy and breastfeeding cause breast cells to fully mature so they can produce milk, and researchers believe these differentiated cells are more resistant to becoming cancerous than cells that never underwent that transformation.
Inherited Gene Mutations
The most well-known genetic risk factors are mutations in the BRCA1 and BRCA2 genes. These genes normally help repair damaged DNA. When they carry harmful mutations, the body loses a critical error-correction system, and damaged cells are more likely to become cancerous. In the general population, about 1 in 400 people carry a harmful BRCA mutation. But in certain populations the rate is much higher. Roughly 2% of people with Ashkenazi Jewish ancestry carry one of three specific BRCA mutations. Elevated rates of founder mutations also appear in Norwegian, Dutch, Icelandic, Hispanic, West African, and African American populations.
Carrying a BRCA mutation does not guarantee a cancer diagnosis, but it raises lifetime risk dramatically compared to the general population. Genetic testing can identify these mutations, and people with a strong family history of breast or ovarian cancer are most likely to benefit from testing.
HER2 Gene Mutations
About 25% of breast cancers involve a mutation in the HER2 gene, which codes for a protein that sits on the surface of breast cells and helps regulate growth. When the gene mutates, the cell produces far too much HER2 protein, sending constant “grow and divide” signals even when the body doesn’t need new cells. This leads to aggressive tumor growth. HER2-positive breast cancers tend to grow faster than other types, though targeted treatments that block the HER2 protein have significantly improved outcomes over the past two decades.
Breast Density
Women with the densest breast tissue face three to five times the risk of breast cancer compared to women with the least dense tissue. Dense breasts contain more glandular and connective tissue relative to fatty tissue, and this shows up as white areas on a mammogram, which can also make tumors harder to spot. Despite the strength of this association, researchers still don’t fully understand the biological mechanism behind it. What is clear is that breast density is partly genetic and partly influenced by hormones, body weight, and age. You can find out your breast density category from a mammogram report.
Alcohol and Other Lifestyle Factors
Alcohol is one of the most clearly established modifiable risk factors. Women who consume two or more drinks per day have approximately a 30% increase in breast cancer risk compared to nondrinkers. A large study of California teachers found that postmenopausal women drinking the equivalent of about two standard drinks daily had a 32% higher risk of invasive breast cancer. The risk increase in premenopausal women was similar in magnitude (21%) but not statistically significant on its own. Alcohol raises estrogen levels and can damage DNA directly, both of which contribute to cancer development.
Obesity after menopause also raises risk because fat tissue becomes the body’s primary source of estrogen once the ovaries stop producing it. More fat tissue means more estrogen circulating in the body. Physical inactivity compounds this effect. Regular exercise, maintaining a healthy weight, and limiting alcohol are the lifestyle factors with the strongest evidence behind them.
Environmental Chemical Exposures
Certain industrial and agricultural chemicals can mimic estrogen in the body, earning them the label “endocrine disruptors.” A 2023 meta-analysis in Frontiers in Oncology identified several chemicals linked to increased breast cancer risk. DDT, a pesticide banned in many countries but still present in the environment, was associated with higher risk, likely because it mimics estrogen and can overstimulate hormone receptors in breast tissue. Chlordane and hexachlorocyclohexane, both organochlorine pesticides, also showed associations with increased risk.
Five specific types of polychlorinated biphenyls (PCBs), chemicals once widely used in electrical equipment and manufacturing, were linked to higher breast cancer risk through multiple mechanisms. Some act directly like estrogen. Others behave like dioxins, a class of highly toxic compounds. Still others stimulate liver enzymes that can alter how the body processes hormones. While individual chemical exposures may carry small risks, the concern is that cumulative, lifelong exposure to many of these compounds adds up.
Why Most Cases Have No Single Cause
For the vast majority of women diagnosed with breast cancer, there is no one identifiable trigger. The disease typically results from an accumulation of small genetic errors over years or decades, nudged along by hormonal exposure, lifestyle factors, and environmental influences. Some of these factors, like family history and breast density, are outside your control. Others, like alcohol intake, physical activity, and body weight, are not. Understanding which risks apply to you can help guide decisions about screening frequency and prevention strategies.